CTLA4 and B-cell chronic lymphocytic leukemia: CTLA-4 is significant for tumors to evade host immune surveillance, and has been implicated in immune dysregulation of lung cancer28, cervical cancer29, breast cancer30, skin cancer31, gastric cancer32, colorectal cancer33, B cell chronic lymphocytic leukemia and non-Hodgkin’s lymphoma34.